Financial News
Latest News about JNJ
Recent news which mentions JNJ
Pro wrestlers, ski instructors and Zoom shrinks: If they can get the COVID vaccine, where’s mine?
Today 16:44 EST
From MarketWatch
From MarketWatch
What Will the Stock Market Do Today? 3 Big Stories to Watch.
Today 10:20 EST
From InvestorPlace
From Benzinga
From Benzinga
Johnson & Johnson's COVID-19 Vaccine Likely To Get EU Approval Early March: Bloomberg
Today 7:17 EST
From Benzinga
Should You Buy Ocugen for Its COVID Vaccine?
Today 6:57 EST
From Motley Fool
From Motley Fool
As New York City COVID-19 variant spreads, mayor promises Johnson & Johnson vaccines by March
February 25, 2021
From MarketWatch
From MarketWatch
5 Surefire Stocks If the Market Crashes
February 25, 2021
From InvestorPlace
From Benzinga
Stock futures mixed after Dow returns to record territory
February 25, 2021
From MarketWatch
4 Robinhood Stocks Billionaires Can't Stop Buying
February 25, 2021
From Motley Fool
Moderna Raises 2021 Base COVID-19 Vaccine Production Plan To 700M Doses
February 25, 2021
From Benzinga
Moderna To Test New COVID-19 Vaccine Targeting South Africa Strain
February 25, 2021
From Benzinga
Biotech ETFs Pop Amid Pending J&J Vaccine Approval
February 24, 2021
From ETF Trends
ABNB Stock: Why Airbnb Is Booking Big Gains Today
February 24, 2021
From InvestorPlace
Disney's Stock Hits All-Time High Amid Vaccine Rollout, Star Debut
February 24, 2021
From Benzinga
Airline Stocks: 2 Big Reasons AAL, DAL and UAL Stock Are Soaring Today
February 24, 2021
From InvestorPlace
Johnson & Johnson's Single-Dose Coronavirus Shot Gets Favorable FDA Review Ahead Of Adcom Meeting
February 24, 2021
Tickers
JNJ
From Benzinga
What Will the Stock Market Do Today? 4 Big Stories to Watch.
February 24, 2021
From InvestorPlace
From Benzinga
FDA says J&J’s COVID-19 vaccine has no ‘specific safety concerns’
February 24, 2021
From MarketWatch
RLFTF: Why Little-Known Relief Therapeutics Is Climbing Today
February 24, 2021
From InvestorPlace
From Motley Fool
1 Big Problem Ocugen Could Face That Investors Might Be Overlooking
February 24, 2021
From Motley Fool
Pfizer, Moderna, J&J Pledge To Make 240M COVID-19 Vaccine Doses Available In US By March-End
February 24, 2021
From Benzinga
March Outlook: Economic Optimism Surrounds New Stimulus, But Yield Surge Hits Tech
February 23, 2021
From Benzinga
Why You Should Keep Your Distance from Ocugen Stock
February 23, 2021
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
